Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · Real-Time Price · USD
4.310
-0.020 (-0.46%)
Nov 22, 2024, 4:00 PM EST - Market closed
Lumos Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 37 | 25 | 30 | 58 | 296 | - | |
| Market Cap Growth | 20.06% | -16.77% | -47.79% | -80.45% | - | - | |
| Enterprise Value | 24 | -17 | -43 | -42 | 191 | - | |
| Last Close Price | 4.31 | 3.18 | 3.61 | 6.93 | 35.71 | - | |
| PS Ratio | 15.95 | 12.27 | 19.85 | 251.81 | 1763.62 | - | |
| PB Ratio | 7.59 | 0.92 | 0.51 | 0.65 | 2.54 | - | |
| P/TBV Ratio | 6.40 | 0.92 | 0.51 | 0.65 | 2.54 | - | |
| EV/Sales Ratio | 10.85 | - | - | - | 1138.59 | - | |
| Debt / Equity Ratio | 0.04 | 0.02 | 0.00 | 0.01 | 0.00 | 0.09 | |
| Asset Turnover | 0.07 | 0.04 | 0.02 | 0.00 | 0.00 | - | |
| Quick Ratio | 2.10 | 5.16 | 10.07 | 18.51 | 19.34 | 3.95 | |
| Current Ratio | 2.66 | 5.69 | 10.73 | 19.43 | 19.88 | 4.01 | |
| Return on Equity (ROE) | -172.83% | -78.34% | -41.82% | -29.61% | -9.39% | -109.98% | |
| Return on Assets (ROA) | -69.64% | -40.53% | -23.20% | -17.09% | -24.43% | -61.78% | |
| Return on Capital (ROIC) | -111.17% | -52.18% | -26.82% | -18.98% | -27.10% | -68.06% | |
| Earnings Yield | -93.67% | -135.23% | -102.72% | -52.54% | -1.91% | - | |
| FCF Yield | -84.97% | -123.55% | -88.11% | -51.24% | -7.77% | - | |
| Buyback Yield / Dilution | 0.71% | 2.73% | -0.47% | -22.97% | 11.44% | 25.58% | |
| Total Shareholder Return | 0.71% | 2.73% | -0.47% | -22.97% | 11.44% | 25.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.